Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement.

Doyle J, Raggatt M, Slavin M, McLachlan SA, Strasser SI, Sasadeusz JJ, Howell J, Hajkowicz K, Nandurkar H, Johnston A, Bak N, Thompson AJ.

Med J Aust. 2019 Jun;210(10):462-468. doi: 10.5694/mja2.50160. Epub 2019 May 19.

PMID:
31104328
2.

Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men.

Medland NA, Chow EP, Bradshaw CS, Read TH, Sasadeusz JJ, Fairley CK.

BMC Infect Dis. 2017 Mar 2;17(1):185. doi: 10.1186/s12879-017-2288-x.

3.

Guarding the sleeping giant: hepatitis B screening and management in patients with hematological malignancy.

Teh BW, Sasadeusz JJ.

Leuk Lymphoma. 2014 Nov;55(11):2426-7. doi: 10.3109/10428194.2014.918973. Epub 2014 Jun 16. No abstract available.

PMID:
24828870
4.

Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men.

Mahony AA, Donnan EJ, Lester RA, Doyle JS, Knox J, Tracy SL, Bowden S, Sasadeusz JJ.

Med J Aust. 2013 Mar 4;198(4):210-4.

PMID:
23451966
5.

Hepatitis B serological changes following allogeneic bone marrow transplantation.

Teh BW, Slavin MA, Szer J, Sasadeusz JJ.

Transpl Infect Dis. 2013 Feb;15(1):98-103. doi: 10.1111/j.1399-3062.2012.00762.x. Epub 2012 Jul 11.

PMID:
22783885
6.

Hepatitis C treatment outcomes in Australian clinics.

Gidding HF, Law MG, Amin J, Ostapowicz G, Weltman M, Macdonald GA, Sasadeusz JJ, Haber PA, George J, Dore GJ.

Med J Aust. 2012 Jun 4;196(10):633-7.

PMID:
22676878
7.

Non-cirrhotic portal hypertension in HIV mono-infected patients.

Jackson BD, Doyle JS, Hoy JF, Roberts SK, Colman J, Hellard ME, Sasadeusz JJ, Iser DM.

J Gastroenterol Hepatol. 2012 Sep;27(9):1512-9. doi: 10.1111/j.1440-1746.2012.07148.x.

PMID:
22497527
8.

Predictors of deferral of treatment for hepatitis C infection in Australian clinics.

Gidding HF, Law MG, Amin J, Macdonald GA, Sasadeusz JJ, Jones TL, Strasser SI, George J, Dore GJ; ACHOS investigator team.

Med J Aust. 2011 Apr 18;194(8):398-402.

PMID:
21495939
9.

Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy.

Sasadeusz JJ, Dore G, Kronborg I, Barton D, Yoshihara M, Weltman M.

Addiction. 2011 May;106(5):977-84. doi: 10.1111/j.1360-0443.2010.03347.x.

PMID:
21205057
10.

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.

Denholm JT, Wright EJ, Street A, Sasadeusz JJ.

Haemophilia. 2009 Mar;15(2):538-43. doi: 10.1111/j.1365-2516.2009.01972.x. Epub 2009 Feb 1.

PMID:
19187189
11.

Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital.

Sasadeusz JJ, Silvers JE, Kent HE, Devenish W, Hocking J, Garland SM.

Aust N Z J Obstet Gynaecol. 2008 Jun;48(3):266-72. doi: 10.1111/j.1479-828X.2008.00857.x.

PMID:
18532957
12.

Current treatment of HIV/hepatitis B virus coinfection.

Iser DM, Sasadeusz JJ.

J Gastroenterol Hepatol. 2008 May;23(5):699-706. doi: 10.1111/j.1440-1746.2008.05382.x. Review.

PMID:
18410604
13.

Why do we not yet have combination chemotherapy for chronic hepatitis B?

Sasadeusz JJ, Locarnini SL, Macdonald G.

Med J Aust. 2007 Feb 19;186(4):204-6.

PMID:
17309424
14.

Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?

Brooks MJ, Sasadeusz JJ, Tannock GA.

Curr Opin Pulm Med. 2004 May;10(3):197-203. Review.

PMID:
15071371
15.

An audit of obstetricians' management of women potentially infected with blood-borne viruses.

Giles ML, Sasadeusz JJ, Garland SM, Grover SR, Hellard ME.

Med J Aust. 2004 Apr 5;180(7):328-32.

PMID:
15059052
16.

Management of healthcare workers after occupational exposure to hepatitis C virus.

Charles PG, Angus PW, Sasadeusz JJ, Grayson ML.

Med J Aust. 2003 Aug 4;179(3):153-7.

PMID:
12885285
17.

Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.

Sasadeusz JJ, Tufaro F, Safrin S, Schubert K, Hubinette MM, Cheung PK, Sacks SL.

J Virol. 1997 May;71(5):3872-8.

19.

Herpes latency, meningitis, radiculomyelopathy and disseminated infection.

Sasadeusz JJ, Sacks SL.

Genitourin Med. 1994 Dec;70(6):369-77. Review. No abstract available.

20.

Systemic antivirals in herpesvirus infections.

Sasadeusz JJ, Sacks SL.

Dermatol Clin. 1993 Jan;11(1):171-85. Review.

PMID:
8382122

Supplemental Content

Loading ...
Support Center